A: Number of alveoli per lung by Lars Knudsen (36605)

“…</p><p>Published online 3 Oct 2007</p><p>PMCID:PMC2078589.</p><p></p> B: Mean alveolar volume. Already after 3 weeks of treatment an increase in alveolar number and a decrease in alveolar volume was observed.…”

Effects of a gap in ECM surface. by Yousef Jamali (218858)

“…Other cells pass over the gap and again create a linear monolayer. For cells cannot ignore the gap and penetrate it. …”

Transcripts with increased translation efficiency during GSC to DGC transition have a significant loss in m6A methylation. by John P. Zepecki (10271291)

“…Crosses represent mean values. E) GSC1: Transcript m6A loss binning correlated with change in TE, vertical blue line indicates median change in TE rank, vertical red line demarcates the top 30% change in TE ranks, horizontal blue lines represent average m6A peak loss across all peaks. …”

Aβ causes the downregulation of GKAP. by Francesco Roselli (211670)

“…(G,H) Aβ42 oligomers caused an apparent increase in GKAP cluster density (due to fragmentation of large clusters) after 1 h of treatment (12.4±4 clusters per 10 µm of dendrite length at baseline vs 15.3±3.7 at 1 h), followed by a sharp decrease in GKAP cluster density (6.4±4.3 and 5.2±1.1 at 6 and 24 h, respectively; the percentage of synaptophysin puncta not matched by GKAP-positive puncta was also reduced (to 80.5±5.7%, 57.3±10.1% and 36.2±5.4%) by treatment with Aβ42 after 1, 6 and 24 h, respectively. …”

Effect of small molecules on the thermal stability of MglA or SspA and their effect on protein-protein interaction. by Algevis P. Wrench (276279)

“…</p>2<p>β-galactosidase activity (expressed as arbitrary units) as a result of pBR-<i>mglA</i>-ω and pACTR-<i>sspA</i>-Zif interaction is expressed as the decrease in the activity in the presence of the chemicals, compared to the control without chemicals after 180 min. …”

The association of participant characteristics with gender norms and condom use at last sex, stratified by sex (N = 530). by Kristin Fladseth (718956)

<i>Escherichia coli</i> strains and plasmids used. by Janet L. Gibson (736950)

Participant characteristics by sex (N = 530). by Kristin Fladseth (718956)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Cell blebs and cytoskeleton under different DMSO concentrations. by Renquan Ruan (721497)

Forest plot of treatment effects of isoleucine–proline–proline/valine–proline–proline on systolic blood pressure in the subgroup analysis according to the baseline blood pressure s... by Aurelie Chanson-Rolle (758940)

Response of the Myc-Rb-E2F network to pulse inputs. by Jaydeep K. Srimani (618692)

“…<p>(A) In response to serum stimulation, the Myc-Rb-E2F can exhibit bistability in E2F levels. …”

Video_1_The Combined Efficacy of a Two-Year Period of Cybernic Treatment With a Wearable Cyborg Hybrid-Assistive Limb and Leuprorelin Therapy in a Patient With Spinal and Bulbar Mu... by Hideaki Nakatsuji (445319)

“…<p>Spinal and bulbar muscular atrophy (SBMA), also known as Kennedy's disease, is a rare, slowly progressive, incurable, and hereditary neurodegenerative disease caused by the testosterone-dependent accumulation of pathogenic polyglutamine-expanded androgen receptor protein. …”

Expression of Linear and Novel Circular Forms of an <em>INK4/ARF</em>-Associated Non-Coding RNA Correlates with Atherosclerosis Risk by Christin E. Burd (236068)

“…<div><p>Human genome-wide association studies have linked single nucleotide polymorphisms (SNPs) on chromosome 9p21.3 near the <em>INK4/ARF (CDKN2a/b)</em> locus with susceptibility to atherosclerotic vascular disease (ASVD). …”

Adsorption of Fumaramide [2]Rotaxane and Its Components on a Solid Substrate:  A Coverage-Dependent Study by Caroline M. Whelan (2529898)

“…A decrease in film order and the absence of a preferred molecular orientation is observed for all three molecules at multilayer coverages. …”

Adsorption of Fumaramide [2]Rotaxane and Its Components on a Solid Substrate:  A Coverage-Dependent Study by Caroline M. Whelan (2529898)

“…A decrease in film order and the absence of a preferred molecular orientation is observed for all three molecules at multilayer coverages. …”